
Backtesting Framework Architect for Algo Trading
Build production-grade backtesting systems that detect overfitting and market biases before deplo...
What You Can Do
You'll architect backtesting systems that separate genuinely profitable strategies from curve-fitted fantasies. The skill guides you through modeling realistic market microstructure, accounting for transaction costs, detecting survivorship bias, and stress-testing strategies across regime changes. You'll implement walk-forward validation, out-of-sample testing, and Monte Carlo simulations to predict actual live performance and identify where backtest results diverge from real trading outcomes.
Features
validate strategy performance across overlapping out-of-sample periods to detect overfitting
stress-test strategy robustness by randomizing market conditions while preserving empirical distributional properties
account for slippage, bid-ask spreads, market impact, and partial fill execution
identify whether backtest results reflect cherry-picked assets or realistic historical universes
evaluate strategy performance across bull/bear markets, volatility regimes, and sector rotations
model commission structures, borrowing costs, and margin requirements specific to your asset class
isolate alpha sources and separate skill from luck using bootstrap resampling and statistical significance testing
identify divergence vectors between idealized backtest assumptions and live execution constraints
Example Output
Backtest Report Summary:
- Strategy Sharpe Ratio (In-Sample): 1.8 → (Out-of-Sample): 0.9 → (Live): 0.4
- Monte Carlo Percentile Analysis: 10th %ile return -8.2%, 90th %ile return +12.5% — Strategy fails stress test below -15% drawdown
- Walk-Forward Degradation: Performance declines 40% when optimized parameters applied to subsequent 6-month periods
- Survivorship Bias Impact: Backtest uses 150 stocks; 23 delisted during period. Excluding delistings inflates returns by 2.1% annually
- Implementation Gaps: Slippage modeling adds 15 bps per trade; transaction costs reduce net Sharpe from 1.2 to 0.7
Verdict: Strategy shows genuine alpha in out-of-sample windows but exhibits significant overfitting. Recommend parameter retuning with tighter regularization constraints before capital deployment.
What's Included
- backtesting-framework-architect.md: complete skill reference with mental models, validation protocols, and troubleshooting
- Walk-Forward Testing Template: spreadsheet/code framework for rolling window optimization and performance analysis
- Monte Carlo Simulation Checklist: step-by-step guide for generating realistic market scenarios and stress-testing parameters
- Microstructure Modeling Worksheet: framework for estimating slippage, market impact, and transaction costs by asset class
- Survivorship Bias Audit Checklist: systematic approach for identifying delisted securities, IPO dates, and data quality issues
- Implementation Gap Diagnostic Tool: template for comparing backtest assumptions versus live execution constraints and quantifying performance divergence
Who It's For
- Quantitative analysts and algo traders — validating strategy performance before deploying capital
- Risk managers and institutional compliance teams — conducting due diligence on external strategy submissions and internal strategy performance claims
- Hedge fund managers and portfolio directors — evaluating strategy robustness and identifying overfitting before LP presentation
- Prop trading developers — architecting backtesting infrastructure that predicts live execution performance
- Fintech engineers and platform architects — designing backtesting engines with realistic market microstructure modeling
Best For
- Validating new algorithmic trading strategies before live deployment
- Diagnosing why live trading performance diverges from backtest results
- Detecting survivorship bias, look-ahead bias, and curve-fitting in strategy development
- Stress-testing strategy robustness across market regimes, volatility regimes, and edge cases
- Due diligence evaluation of external strategy submissions for institutional investors







